Peroxitech Put $25 Million Behind a Nine-Amino-Acid Bet on Saving Injured Lungs

The Philadelphia spinout is trying to stop acute lung injury before oxidative damage snowballs. Its unusually small peptide has survived mice, pigs and a $25 million financing - but the decisive human test still lies ahead.